HSCS
Price
$3.16
Change
+$0.13 (+4.29%)
Updated
Jan 14 closing price
Capitalization
10.04M
Intraday BUY SELL Signals
MBOT
Price
$2.16
Change
+$0.04 (+1.89%)
Updated
Jan 14 closing price
Capitalization
145.06M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HSCS vs MBOT

Header iconHSCS vs MBOT Comparison
Open Charts HSCS vs MBOTBanner chart's image
HeartSciences
Price$3.16
Change+$0.13 (+4.29%)
Volume$24.27K
Capitalization10.04M
Microbot Medical
Price$2.16
Change+$0.04 (+1.89%)
Volume$966.61K
Capitalization145.06M
HSCS vs MBOT Comparison Chart in %
HSCS
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HSCS vs. MBOT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCS is a Hold and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (HSCS: $3.16 vs. MBOT: $2.16)
Brand notoriety: HSCS and MBOT are both not notable
HSCS represents the Medical/Nursing Services, while MBOT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HSCS: 42% vs. MBOT: 46%
Market capitalization -- HSCS: $10.04M vs. MBOT: $145.06M
HSCS [@Medical/Nursing Services] is valued at $10.04M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $145.06M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.36B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.82B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.9B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSCS’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • HSCS’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than HSCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSCS’s TA Score shows that 5 TA indicator(s) are bullish while MBOT’s TA Score has 5 bullish TA indicator(s).

  • HSCS’s TA Score: 5 bullish, 4 bearish.
  • MBOT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both HSCS and MBOT are a good buy in the short-term.

Price Growth

HSCS (@Medical/Nursing Services) experienced а +3.27% price change this week, while MBOT (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.93%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +22.87%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.30%. For the same industry, the average monthly price growth was +0.24%, and the average quarterly price growth was -0.40%.

Reported Earning Dates

MBOT is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (+4.93% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($145M) has a higher market cap than HSCS($10M). MBOT YTD gains are higher at: 8.000 vs. HSCS (2.265). HSCS has higher annual earnings (EBITDA): -7.98M vs. MBOT (-13.97M). MBOT has more cash in the bank: 80.2M vs. HSCS (2.79M). MBOT has less debt than HSCS: MBOT (899K) vs HSCS (1.95M). HSCS has higher revenues than MBOT: HSCS (6.25K) vs MBOT (0).
HSCSMBOTHSCS / MBOT
Capitalization10M145M7%
EBITDA-7.98M-13.97M57%
Gain YTD2.2658.00028%
P/E Ratio0.55N/A-
Revenue6.25K0-
Total Cash2.79M80.2M3%
Total Debt1.95M899K217%
FUNDAMENTALS RATINGS
MBOT: Fundamental Ratings
MBOT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HSCSMBOT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 25 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
HSCS
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INHD1.370.05
+3.79%
Inno Holdings Inc.
BTCS3.010.04
+1.35%
BTCS
JBL241.342.99
+1.25%
Jabil
CCBG43.710.19
+0.44%
Capital City Bank Group
REVG68.15N/A
N/A
REV Group

HSCS and

Correlation & Price change

A.I.dvisor tells us that HSCS and HSDT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSCS and HSDT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
+4.29%
HSDT - HSCS
32%
Poorly correlated
+1.16%
VAPO - HSCS
29%
Poorly correlated
N/A
PSNL - HSCS
22%
Poorly correlated
+5.92%
PFSA - HSCS
22%
Poorly correlated
+9.47%
MBOT - HSCS
21%
Poorly correlated
+1.89%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with CORBF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+1.89%
CORBF - MBOT
33%
Loosely correlated
N/A
RCEL - MBOT
33%
Poorly correlated
+6.67%
OTCFF - MBOT
32%
Poorly correlated
+12.46%
BNGO - MBOT
32%
Poorly correlated
-1.90%
AIMD - MBOT
32%
Poorly correlated
+0.31%
More